TrialPloS one2020

Virologic and immunologic outcomes of treatment with integrase inhibitors in a real-world setting: The RESPOND cohort consortium.

Bastian Neesgaard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.